baber/WOPTO huggingface dataset:
Patent CA-2615008-A1 (CA)
Title: Method and apparatus for providing commercials suitable for viewing when fast-forwarding through a digitally recorded program
Inventor: LEARY PATRICK J
IPC: H04N5/76
Filed: 2007-12-14
Abstract: A method and apparatus is provided for rendering a video program. The apparatus includes a computer-readable storage medium and a processor responsive to the computer-readable storage medium and to a software program. The software program, when loaded into the processor, is operative to: receive a user command specifying a fast forward operation through a program; identify a first commercial associated with a commercial break in the program while fast forwarding therethrough; and select a substitute commercial that appears to be rendered at the normal presentation rate while fast forwarding through the program; and play the substitute commercial.
Patent CA-2615164-A1 (CA)
Title: Self-hedging multi-layered investment system and method using internal contractual relationships
Inventor: MASUCCI SAMUEL R
IPC: G06Q40/00
Filed: 2006-06-19
Abstract: Proxy assets providing risk management capabilities are described, such as liquid interests in illiquid assets and economic indicators, without the deficiencies associated with other types of financial instruments. A proxy assets set is defined to respond to one or more indices. Each proxy asset may have a share value and a number of shares. The proxy assets can have a proxy assets set account value equal to a sum over all proxy assets of the products of the share value and the number of shares. At least one proxy asset account value per share is a function of an index. Two or more trusts including an Up-Holding trust and a Down-holding trust may hold various of the proxy assets.
Patent CA-2619980-A1 (CA)
Title: Tri-line power cable for electrical submersible pump
Inventor: TETZLAFF STEVEN K
IPC: H01R13/00
Filed: 2006-08-24
Abstract: A power line for an electrical submersible pump has three metallic impermeable tube (35). A single electrical conductor (28) is located within each of the tubes. Each conductor has at least one elastomeric insulation layer (30) surrounding it. An annular portion of the insulation layer of each of the electrical conductors is in tight contact with the tube to form a seal . The annular portions may be annular crimps (37) formed in the tube at intervals.  The annular portion could also be a continuous seal caused by swelling of the insulation layer due to contact with a hydrocarbon.
Patent CA-2624265-A1 (CA)
Inventor: MATSUZAKI TAKEHARU
IPC: F15B11/05
Filed: 2007-03-26
Abstract: A hydraulic control apparatus (1) includes a switch valve (11) , a valve support chamber (35) , a flow control valve (12) movable therein, an on-off valve (13) movable within a communication path chamber (12a) located inside the flow control valve (12)', and a valve control device 14. The on-off valve (13) can open and shut off a communication path X between a cylinder line (32) and a switch valve line (33) . A restrictor formed between the flow control valve (12) and a wall defining the valve support chamber (35) connects the cylinder line (32) and the communication path chamber (12a) . The restrictor opening is changed in correspondence with movement of the flow control valve (12) . When the switch valve (11) is located at the drainage position, the valve control device (14) applies a pilot pressure lower than the pressure in the cylinder line (32) to a back pressure chamber (12d) of the flow control valve (12) , thereby moving the on-off valve (13) in a direction for opening the communication path X.
Patent CA-2624366-A1 (CA)
Inventor: ANDERSEN PETER
IPC: A22C15/00
Filed: 2008-03-06
Abstract: The disclosure relates to a fixing device (1) and a method for fixing a carcass (37), e.g. during processing the carcass at a slaughterhouse, such as a carcass hanging head-down from a gambrel, wherein the device (1) comprises mouth-engaging fixing means (7).
Patent CA-2625364-A1 (CA)
Inventor: WOODBURY BRIAN
IPC: H04B7/00
Filed: 2006-10-24
Abstract: A method, according to the various aspects of the present invention, is performed by a wireless cell for improving communication between the wireless cell and at least one wireless client, the wireless cell having at least two channels. The method includes, in any practical order, the wireless cell receiving a notice of the application executed by each one of at least a portion of the clients; the wireless cell measuring the transmission and reception performance between the wireless cell and each one of the clients for each channel; and the wireless cell selecting one of the channels in accordance with a prioritized list of applications.
Patent CA-2625825-A1 (CA)
Inventor: FERRIERE CHRISTIAN
IPC: E02D27/02
Filed: 2006-10-27
Abstract: Le bâtiment à usage d'habitation notamment dont les composants sont majoritairement préfabriqués en usine, comprend une fondation (1) supportant une assise de bâtiment, des murs dressés sur l'assise, un plafond en appui sur les murs et une toiture en appui sur les murs, se caractérise essentiellement en ce que la fondation (1) est constituée de blocs (10) de fondation coulés sur site, dans des fouilles appropriées, joints par des formes de longrines (11) également coulées sur site dans des fouilles appropriées et que chaque bloc de fondation (10) est équipé d'un pilier vertical (12), préfabriqué en usine comportant une face plane supérieure horizontale, les faces planes supérieures des piliers (12) de la fondation étant toutes disposées selon un même plan horizontal et reçoivent en appui, à distance du sol, l'assise du bâtiment. La présente invention est également relative à un procédé et aux moyens utilisés pour la réalisation d'éléments de mur manuellement ou automatiquement en continu.
Patent CA-2627077-A1 (CA)
Title: Low bit-rate universal audio coder
Inventor: PISHEHVAR RAMIN
IPC: G10L19/06
Filed: 2008-03-10
Abstract: A biologically-inspired process for universal audio coding based on neural spikes is presented. The process is based on the generation of sparse two-dimensional time-frequency representations of audio signals, called spikegrams. The spikegrams are generated by projecting the audio signal onto a set of over-complete adaptive gamma-chirp kernels. A masking model is applied to the spikegrams to remove inaudible spikes and to increase the coding efficiency. In respect of one aspect of the invention, the masked spikegram is then quantized using a genetic-algorithm-based quantizer (or its simplified linear version). The values are then differentially coded using graph based optimization and entropy coded afterwards.
Patent CA-2628428-A1 (CA)
Inventor: URABE HIROYUKI
IPC: B60W10/10
Filed: 2006-12-21
Abstract: A control input for operating an actual vehicle actuator and a control input for operating a vehicle model are determined by an FB distribution law 20 on the basis of a difference between a reference state amount determined by a vehicle model 16 and an actual state amount of an actual vehicle 1 (state amount error) such that the state amount error is approximated to zero, and then an actuator device 3 of the actual vehicle 1 and the model vehicle 16 are operated on the basis of the control inputs. The FB  distribution law 20 determines a control input for operating the model such that a state amount error is approximated to zero while restraining a predetermined restriction object amount from deviating from a permissible range. A vehicle control device capable of enhancing robustness against disturbance factors or their changes while performing operation control of actuators that is suited to behaviors of an actual vehicle as much as possible is provided.
Patent CA-2628953-A1 (CA)
Title: Base station system performance measurement system in a gsm radio communication network
Inventor: BORKOVIC BORIS
IPC: H04W16/06
Filed: 2006-11-03
Abstract: The invention relates to a system an a method for self optimizing a radio communication network comprising a plurality of radio cells, the system means for monitoring the network resource consumption and quality parameters individually for each cell, and means for distributing the network traffic dynamically between neighboring radio cells in order to maintain satisfactory quality of service in each radio cell.
Patent CA-2630235-A1 (CA)
Inventor: SILVER DAVID ISAAC
IPC: A61K31/4439
Filed: 2005-12-20
Abstract: The invention provides orally disintegrating tablets that readily disintegrates in the mouth, releasing enteric coated drug sub-tablets.
Patent CA-2630848-A1 (CA)
Inventor: SAMNICK SAMUEL
IPC: A61P35/00
Filed: 2006-11-27
Abstract: The present invention provides a 3-iodo-L-phenylalanine or 4-iodo-L-phenylalanine for the preparation of a pharmaceutical composition for the treatment of malignant neoplasia. Moreover, the invention provides a method for the treatment of malignant neoplasia, the method comprising the steps of administering 3-iodo-L-phenylalanine or 4-iodo-L-phenylalanine to a subject in need thereof and a pharmaceutical composition comprising 3-iodo-L-phenylalanine or 4-iodo-L-phenylalanine.
Patent CA-2632210-A1 (CA)
Inventor: GLINERT ROBERT
IPC: G02C5/00
Filed: 2006-12-08
Abstract: The present invention relates to eyeglasses and containers for securing eyeglasses. In particular, the present invention relates to a device comprising an eyeglasses segment attached to an eyeglasses container, and related systems and kits.
Patent CA-2633055-A1 (CA)
Inventor: MINEGISHI AKIRA
IPC: B62D65/06
Filed: 2005-11-29
Abstract: A method of installing door glass (15) on a vehicle door (16). The door glass is tilted relative to the front-rear direction of a vehicle to reduce the length in the front-rear direction of the door glass. The tilted door glass is lowered to position it between a pair of sashes (121, 122) provided at the front and rear of the vehicle door. The tilt of the door glass is corrected to a predetermined level to fit the door glass into the front and rear sashes and then the door glass is lowered.
Patent CA-2634516-A1 (CA)
Inventor: HASENZAHL SIEGHARD
IPC: G16H20/17
Filed: 2008-06-10
Abstract: A disease management system, methods, and devices are shown and described. In one embodiment, the system includes an infusion pump and a remote controller with the ability to be paired to each other. A method to verify a wireless connection between an infusion pump and a remote controller is shown and described herein. In a further embodiment, a method to verify a wireless connection between an infusion pump and a remote controller is provided. In addition, a method of operating a diabetes management system is provided in which the system includes an infusion pump and at least a remote controller.
Patent CA-2635781-A1 (CA)
Title: Multi-dimensional ion mobility spectrometry apparatus and methods
Inventor: WU CHING
IPC: G01N27/622
Filed: 2006-12-29
Abstract: Various embodiments of a multi-dimensional ion mobility analyzer are disclosed that have more than one drift chamber and can acquire multi-dimensional ion mobility profiles of substances. The drift chambers of this device can, for example, be operated under independent operational conditions to separate charged particles based on their distinguishable chemical/physical properties.  The first dimension drift chamber of this device can be used either as a storage device, a reaction chamber, and/or a drift chamber according to the operational mode of the analyzer. Also presented are various methods of operating an ion mobility spectrometer including, but not limited to, a continuous first dimension ionization methods that can enable ionization of all chemical components in the sample regardless their charge affinity.
Patent CA-2639638-A1 (CA)
Inventor: WATANABE SHINYA
IPC: G02B6/13
Filed: 2008-09-17
Abstract: To provide a PLC and the like, which can improve the optical coupling efficiency by coupling an optical element to a light waveguide part without having a gap. The PLC includes a light waveguide part and an optical element mount part. The light waveguide part has a lower clad layer, a core layer, and an upper clad layer formed on a part of a silicon substrate as a substrate. The optical element mount part has an LD, which is to be optically coupled at the light waveguide end face as an end face of the light waveguide, loaded on the silicon substrate. At the light waveguide end face, an end face of the lower clad layer is recessed with respect to an end face of the core layer and an end face of the upper clad layer towards a direction away from the LD.
Patent CA-2642071-A1 (CA)
Title: Removable platform coil holder
Inventor: LEENDERTSE PAUL
IPC: B65D85/24
Filed: 2008-10-20
Abstract: For simplifying and improving the speed of the task of storing, protecting and retrieving nail coils. The cylindrical container attaches to a workers belt and contains a removable platform upon which coil nails are stacked and stored. The solid cylindrical container protects deformity of the coil nails. The removable platform is in the shape of an inverted "T" allowing coil nails to be slid over vertical portion of the inverted "T"  which keeps nails securely stacked on top of the base of the inverted "T" platform. The removable platform allows easy retrieval of individual coils when a user needs to reload his/her pneumatic gun. The removable platform also allows easy restocking of the cylindrical container by allowing the platform to be taken out and stacked full again before inserting the freshly stacked platform back into the cylindrical container where the coil nails are stored and kept safe from malformity.
Patent CA-2643337-A1 (CA)
Title: Cancer treatment combining lymphodepleting agent with ctls and cytokines
Inventor: CAI ZELING
IPC: A01N63/00
Filed: 2007-02-23
Abstract: In a cancer treatment combining cell therapy with chemotherapy, autologous CD8+ T cells are obtained from a patient, activated ex vivo by contacting them with xenogenic antigen presenting cells loaded with selected peptide antigen, thereby generating antigen- specific activated cytotoxic T lymphocytes. Such activated CTLs are administered to the patient in conjunction with a lymphodepletion and CTL maintenance regimen comprising a non-myeloblative but lymphdepleting agent, such as cladribine or denileukin diftitox, and interleukin-2 and interferon-.alpha.-2b stimulatory cytokines.
Patent CA-2643567-A1 (CA)
Inventor: CHURCHILL FREDERICK
IPC: F03B15/00
Filed: 2008-11-10
Abstract: A directing system for directing fluid entering an axial flow turbine along an inlet flow direction. The turbine includes a plurality of turbine blades. The directing system includes a base structure, a plurality of directing segments attached to the base structure, downstream of the base structure, and a directing segment adjustment system for adjustably positioning the directing segments between a retracted configuration and a deployed configuration. The directing segments, in the deployed configuration, extend beyond the base structure in a direction transversal to the inlet flow direction and deflect the fluid towards an outer circumference of the plurality of turbine blades corresponding to a higher torque area of the blades. A directing system for directing fluid entering a cross-flow turbine is also disclosed. In the cross-flow turbine, the fluid is directed towards a centerline of the rotor of the turbine, which is a high torque area of the turbine blades.
Patent CA-2643984-A1 (CA)
Title: Procede et kits de purification
Inventor: BOONHAM NEIL
IPC: G01N33/558
Filed: 2007-03-12
Abstract: Procédé servant à séparer un acide nucléique d'un échantillon liquide, ledit procédé comprenant les étapes consistant à faire couler un échantillon liquide contenant ou supposé contenir ledit acide nucléique le long d'une membrane absorbante, par exemple d'un dispositif d'immunochromatographie sur membrane classique, de façon à ce que l'acide nucléique soit réparti sur la longueur de la membrane. L'acide nucléique peut être détecté sur la membrane.
Patent CA-2644243-A1 (CA)
Inventor: KLEPPER ROBERT E
IPC: C01B32/40
Filed: 2007-03-02
Abstract: An apparatus (10) designed to form syn gas from carbonaceous materials such as coal includes a devolatilization reactor (14) in combination with a reformer reactor (16) which subsequently forms syn gas. The reformer reactor, in turn, is in communication with a particulate separator (18). The devolatilization reactor is fed with material using a compression feeder (12) which drives air from the feed material, compresses it in a feed zone forming a seal between the feed hopper and the devolatiliization reactor. The reformer reactor (16), as well as the particulate separators (18,20), are maintained in a heated furnace (77) so that the temperature of the formed syn gas does not decrease below the reaction temperature until particulate material has been separated.
Patent CA-2646180-A1 (CA)
Title: Method for making silicon for solar cells and other applications
Inventor: AMENDOLA STEVEN
IPC: C01B33/02
Filed: 2007-03-14
Abstract: A method for preparation of high purity silicon suitable for photovoltaic cells using reduction of silica, which is pre-purified in an aqueous solution, in presence of a reducing agent, preferably carbonaceous agent, where the pre-purified silica has a low amount of boron suitable for photovoltaic cells is described.
Patent CA-2646283-A1 (CA)
Title: Impact of calcium phosphate complex on dental caries
Inventor: TANCREDI DORIS
IPC: A61K8/00
Filed: 2007-04-05
Abstract: The present invention relates to chewing gum and confectionery compositions and methods for reducing dental caries in mammals. In particular, the compositions may include a gum base or carrier, sweetening agents and casein phosphopeptide-calcium phosphate (CPP-ACP). The compositions may be employed to slow the progression and enhance the regression of carious lesions in mammals, particularly in humans.
Patent CA-2646585-A1 (CA)
Inventor: THATCHER ROBERT
IPC: C07D401/10
Filed: 2007-03-19
Abstract: Compounds of formula (I) and salts and solvates are provided: formula (I). Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.
Patent CA-2647807-A1 (CA)
Title: Communicating member, medical container using the same, and infusion preparation tool set
Inventor: OKIYAMA TADASHI
IPC: A61J1/10
Filed: 2007-03-28
Abstract: A communicating member for a medical container has a plate member (4) having a first opening (5) and a second opening (6); a first connection port (15) including the first opening part (5), a plug body (9) for sealing the first opening part (5), and a first generally tubular member (19) communicating with the first opening (5); a second connection port (16) including the second opening part (6) and a partition wall member (13) for sealing the second opening part (6); and a continuous wall (17) disposed on the first generally tubular member (19) side of the plate member (4) and erected from the plate member (4) so as to surround both the first opening part (5) and the second opening part (6) in a plan view of the plate member. The first generally tubular member (19) has a first communication part (20) opened to the second opening part (6) side.
Patent CA-2647942-A1 (CA)
Title: Combined mucosal and parenteral immunization against hiv
Inventor: RAPPUOLI RINO
IPC: A61K39/21
Filed: 2007-03-29
Abstract: HIV antigens are mucosally administered in one or more priming immunization(s), and then HIV antigens are parenterally administered in one or more boosting immunization(s). Thus the invention provides a method for raising an immune response in a patient, comprising: (i) administering a HIV antigen to the patient via a mucosal route; and then (ii) administering a HIV antigen to the patient via a parenteral route. The antigens will typically be adjuvanted. Preferred mucosal immunizations are via the intranasal route using a detoxified mutant of E.coli heat labile toxin as the adjuvant. Preferred parenteral immunizations are via the intramuscular route using an oil-in-water emulsion adjuvant.
Patent CA-2648375-A1 (CA)
Inventor: GRAETZEL MICHAEL
IPC: H01L51/00
Filed: 2007-04-03
Abstract: This invention pertains to light emitting materials comprising novel ortho-metalated transition metal complexes [C^N]2M(T)(L), comprising chelate dialkylamino-substituted C^N ligands, monodentate neutral ligand (L) having sp~ hybridized N atom and a monodentate anionic ligand (T) chosen among CN,- CNO-, CNS-. It has been surprisingly found that when the metal has bound thereto in addition to substituted orthometalated ligands, both an anion chosen among cyanide, thiocyanate, cyanate, possessing strong .sigma. donor and .pi. acceptor properties, and a monodentate neutral ligand L, as above defined, said ligands advantageously participate in the emission process, significantly shifting emission towards higher energies (blue-shift) and enabling appreciable improvement of the emission efficiency of complexes [C^N]2M(T)(L). Still objects of the invention are the use of said light emitting materials and organic light emitting device comprising said light emitting material.
Patent CA-2649213-A1 (CA)
Title: Imidazo compounds
Inventor: JELAKOVIC STJEPAN
IPC: A61K31/4188
Filed: 2007-04-12
Abstract: The application relates to novel heterocyclic compounds of the general formula (I) and salts, preferably pharmaceutically acceptable salts, thereof in which R, R1, R2, Q, m and n have the meanings explained in detail in the description, a process for their preparation and the use of these compounds as medicaments, in particular as aldosterone synthase inhibitors.
Patent CA-2649325-A1 (CA)
Inventor: JENDRISAK JEROME
IPC: C12N15/64
Filed: 2007-04-16
Abstract: The present invention relates to kits and methods for efficiently generating 5' capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. The invention is used to obtain novel compositions of such modified- nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production o 5'-capped RNA having a modified cap nucleotide and for in vitro or in vivo production o polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA for a variety of research, therapeutic, and commercial applications. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5'-diphosphate, such as RNA synthesized in vitro or obtained from a biological source, including prokaryotic mRNA that is in a mixture with other prokaryotic and/or eukaryotic nucleic acids. The method for capturing modified-nucleotide- capped RNA also provides methods and kits for obtaining only type-specific or condition- specific modified-nucleotide-capped RNA by cap-dependent subtraction of that portion of the captured modified-nucleotide-capped RNA in cells of one type or condition that is the same as RNA in cells of another type or condition. The invention further provides methods and kits for using a capping enzyme system and modified cap nucleotides for labelin uncapped RNA comprising primary RNA transcripts or RNA having a 5 '-diphosphate with detectable dye or enzyme moieties.